Dynorphin A (1-17) is a full-length opioid fragment often used to analyze extended receptor-interaction domains. Its sequence supports mapping of aromatic clusters and basic residue contributions. Researchers explore its dynamic conformation for insights into peptide-receptor docking. The molecule contributes to opioid structural studies.
CAT No: D05037
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.